Cargando…
Current status of in vivo bioanalysis of nano drug delivery systems
The development of nano drug delivery systems (NDDSs) provides new approaches to fighting against diseases. The NDDSs are specially designed to serve as carriers for the delivery of active pharmaceutical ingredients (APIs) to their target sites, which would certainly extend the benefit of their uniq...
Autores principales: | Wang, Tingting, Zhang, Di, Sun, Dong, Gu, Jingkai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Xi'an Jiaotong University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322761/ https://www.ncbi.nlm.nih.gov/pubmed/32612868 http://dx.doi.org/10.1016/j.jpha.2020.05.002 |
Ejemplares similares
-
Bioanalysis in drug discovery and development
por: Pandey, Saurabh, et al.
Publicado: (2010) -
Bioanalysis in the Age of New Drug Modalities
por: Shi, Jing, et al.
Publicado: (2021) -
Generation, Characterization, and Quantitative Bioanalysis of Drug/Anti-drug Antibody Immune Complexes to Facilitate Dedicated In Vivo Studies
por: Hoffmann, Eugenia, et al.
Publicado: (2019) -
PCR in bioanalysis /
Publicado: (1998) -
Multiple nano-drug delivery systems for intervertebral disc degeneration: Current status and future perspectives
por: Liu, Wenzhao, et al.
Publicado: (2022)